Page last updated: 2024-10-22

alprazolam and Disease, Pulmonary

alprazolam has been researched along with Disease, Pulmonary in 1 studies

Alprazolam: A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238)
alprazolam : A member of the class of triazolobenzodiazepines that is 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine carrying methyl, phenyl and chloro substituents at positions 1, 6 and 8 respectively. Alprazolam is only found in individuals that have taken this drug.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tuncok, Y1
Akpinar, O1
Guven, H1
Akkoclu, A1

Other Studies

1 other study available for alprazolam and Disease, Pulmonary

ArticleYear
The effects of theophylline on serum alprazolam levels.
    International journal of clinical pharmacology and therapeutics, 1994, Volume: 32, Issue:12

    Topics: Adult; Aged; Alprazolam; Coronary Artery Disease; Drug Interactions; Drug Therapy, Combination; Fema

1994